(Q42164923)

English

Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia

scientific article published on February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

1 reference

based on heuristic

inferred from title

author name string

Susumu Sasaki

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Noriko Kuwahara

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Keiko Kunitomo

3

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Sanae Harada

4

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Takashi Yamada

5

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Akihiro Azuma

6

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Kazuo Takeda

7

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Masao Nakagawa

8

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

386-389

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Relationship between plasma oxidized low-density lipoprotein and the coronary vasomotor response to acetylcholine in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Low density lipoprotein particle size and risk of early-onset myocardial infarction in women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Homocysteine and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902257-3

7 January 2021

Identifiers

10.1016/S0002-9149(01)02257-3

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

release_h2pooj4a45fgroxoypxoibw7ke

1 reference

https://api.fatcat.wiki/v0/release/h2pooj4a45fgroxoypxoibw7ke

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42164923&oldid=1935065458"